Literature DB >> 18794742

Early communication about an ongoing safety review Botox and Botox Cosmetic (botulinum toxin type A) and Myobloc (botulinum toxin type B).

.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18794742     DOI: 10.1097/01.PSN.0000335818.00036.c5

Source DB:  PubMed          Journal:  Plast Surg Nurs        ISSN: 0741-5206


× No keyword cloud information.
  19 in total

1.  Healing beauty? More biotechnology cosmetic products that claim drug-like properties reach the market.

Authors:  Andrea Rinaldi
Journal:  EMBO Rep       Date:  2008-11       Impact factor: 8.807

2.  Enhanced Delivery of Erythropoietin Across the Blood-Brain Barrier for Neuroprotection against Ischemic Neuronal Injury.

Authors:  Feng Zhang; Juan Xing; Anthony Kian-Fong Liou; Suping Wang; Yu Gan; Yumin Luo; Xuming Ji; R Anne Stetler; Jun Chen; Guodong Cao
Journal:  Transl Stroke Res       Date:  2010-06       Impact factor: 6.829

Review 3.  Anal Fissure.

Authors:  Jennifer Sam Beaty; M Shashidharan
Journal:  Clin Colon Rectal Surg       Date:  2016-03

Review 4.  Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction.

Authors:  Koenraad De Boulle; Steven Fagien; Boris Sommer; Richard Glogau
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

5.  Botulinum Toxin Deaths: What is the Fact?

Authors: 
Journal:  J Cutan Aesthet Surg       Date:  2008-07

6.  Experience (mostly negative) with the use of sympathomimetic agents for weight loss.

Authors:  Mario A Inchiosa
Journal:  J Obes       Date:  2010-08-12

Review 7.  Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).

Authors:  Brian J Hoare; Margaret A Wallen; Christine Imms; Elmer Villanueva; Hyam Barry Rawicki; Leeanne Carey
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

8.  Spasticity.

Authors:  Allison Brashear; Kelly Lambeth
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

9.  Use and outcomes of antifibrinolytic therapy in patients undergoing cardiothoracic surgery at 20 academic medical centers in the United States.

Authors:  Karl Matuszewski; Robert Schoenhaus; Mary Ellen Bonk; James Lane; Michael Oinonen
Journal:  P T       Date:  2008-02

Review 10.  A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD.

Authors:  Daniel E Hilleman; Mark A Malesker; Lee E Morrow; Dan Schuller
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.